Quick Access

VRK2 Knockout HAP1 Cell Line

VRK2 Knockout HAP1 Cell Line

VRK2 Knockout HAP1 Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.

Cat. No EDC08018
Species Human
Cell Line HAP1
Gene VRK2
Size 1×10⁶cells

Product Details

Cat.No. EDC08018 Product Name VRK2 Knockout HAP1 Cell Line
Species Human Cell Line HAP1
Cellosaurus ID CVCL_0F62 NCBI Gene ID
Cell Line Synonyms Highly Aggressively Proliferating Immortalized Gene
Summary
This gene encodes a member of the vaccinia-related kinase (VRK) family of serine/threonine protein kinases. The encoded protein acts as an effector of signaling pathways that regulate apoptosis and tumor cell growth. Variants in this gene have been associated with schizophrenia. Alternative splicing results in multiple transcript variants that differ in their subcellular localization and biological activity. [provided by RefSeq, Jan 2014]
Digestion Time 2 min
Morphology Adherent Passage Ratio 1:8~1:10
Complete Culture Medium IMDM+10%FBS Freezing Medium 90%FBS+10%DMSO
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.

FAQ

The choice depends on the experimental question. The Knockout line is appropriate for asking whether VRK2 is required for its reported functions in MAPK signaling regulation, apoptosis modulation, or mitochondrial outer membrane localization. Overexpression is useful for testing whether elevated VRK2 activity is sufficient to drive these processes, or for distinguishing VRK2A (membrane-bound) from VRK2B (soluble) isoform functions. For VRK kinase research, the EDITGENE Knockout line in HAP1 provides clean genetic ground for dissecting VRK2-specific functions, particularly given functional overlap with VRK1. The near-haploid background allows complete VRK2 loss to be assessed without complications from heterozygous expression. Rescue with wild-type, kinase-dead, or isoform-specific (VRK2A vs VRK2B) constructs is essential for mechanistic dissection.
Yes. VRK2 rescue experiments require attention to isoform specificity and subcellular localization: • Construct design: use codon-modified VRK2A or VRK2B sequences with C-terminal tags depending on which isoform function is being investigated. The isoforms have distinct C-termini and subcellular localizations. • Isoform-specific rescue: VRK2A (membrane-bound) and VRK2B (soluble) should be rescued separately to dissect isoform-specific functions; rescue with both is informative for understanding combined activity. • Kinase-dead rescue: an active site mutation (typically K169E or D175A) serves as the catalytic activity specificity control. • Localization validation: confirm VRK2A targeting to ER/mitochondrial outer membrane, or VRK2B nuclear/cytoplasmic distribution, by immunofluorescence. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
Contact Us
*
*
*
How did you hear about us: